BRISTOL-MYERS SQUIBB CO
BRISTOL-MYERS SQUIBB CO
Action · US1101221083 · BMY · 850501 (XNYS)
Aperçu Indicateurs financiers
48,36 USD
1,00 % 0,48 USD
NYSE (XNYS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 22:18

Cours actuels de BRISTOL-MYERS SQUIBB CO

BourseTickerDeviseDernier échangeCoursVariation journalière
XNYS: NYSE
NYSE
BMY
USD
06.06.2025 22:18
48,36 USD
47,84 USD
+1,09 %
XETR: XETRA
XETRA
BRM.DE
EUR
06.06.2025 15:35
42,45 EUR
42,31 EUR
+0,32 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 0,14 % 1,34 % -19,15 % -18,10 % 16,70 % -21,15 %

Profil de l'entreprise pour BRISTOL-MYERS SQUIBB CO Action

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Fonds investis

Les fonds suivants ont investi dans : BRISTOL-MYERS SQUIBB CO investi :

Fonds
iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)
Vol. en millions
34.308,76
Part (%)
2,38 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. en millions
6.889,62
Part (%)
1,89 %
Fonds
iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)
Vol. en millions
2.069,92
Part (%)
1,68 %
Fonds
iShares MSCI World Quality Dividend UCITS ETF USD (Acc)
Vol. en millions
598,56
Part (%)
1,26 %
Fonds
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist)
Vol. en millions
2.556,87
Part (%)
0,98 %

Données de l'entreprise

Nom BRISTOL-MYERS SQUIBB CO
Société Bristol-Myers Squibb Company
Symbole BMY
Site web https://www.bms.com
Marché d'origine XNYS NYSE
WKN 850501
ISIN US1101221083
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - General
PDG Dr. Christopher S. Boerner Ph.D.
Capitalisation boursière 89 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 34,1 T
Adresse 430 East 29th Street, 10016 New York
Date d'introduction en bourse 1999-05-14
Dividendes de 'BRISTOL-MYERS SQUIBB CO'
Date ex-dividende Dividende par action
04.04.2025 0,62 USD
03.01.2025 0,62 USD
04.10.2024 0,60 USD
05.07.2024 0,60 USD
04.04.2024 0,60 USD
04.01.2024 0,60 USD
05.10.2023 0,57 USD
06.07.2023 0,57 USD
06.04.2023 0,57 USD
05.01.2023 0,57 USD

Fractionnements d'actions

Date Fractionnement
07.08.2001 1000000:951777
01.03.1999 2:1
03.03.1997 2:1
10.06.1987 2:1
27.05.1983 2:1
31.05.1977 2:1

Symboles boursiers

Nom Symbole
Frankfurt BRM.F
NYSE BMY
XETRA BRM.DE

Autres actions

Les investisseurs qui détiennent BRISTOL-MYERS SQUIBB CO ont également les actions suivantes dans leur portefeuille :
ADOBE INC
ADOBE INC Action
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Action
AMAZON.CO INC
AMAZON.CO INC Action
AMERICAN STATES WATER CO
AMERICAN STATES WATER CO Action
APPLE INC
APPLE INC Action
CATERP.FIN.SER. 13/23 MTN
CATERP.FIN.SER. 13/23 MTN Obligation
COCA-COLA CO
COCA-COLA CO Action
META PLATFORMS INC
META PLATFORMS INC Action
MICROSOFT CORP
MICROSOFT CORP Action
NVIDIA CORP
NVIDIA CORP Action
REMGRO J. GBP 16/21
REMGRO J. GBP 16/21 Obligation
ROCKET LAB USA
ROCKET LAB USA Action
TESLA INC
TESLA INC Action
WALT DISNEY INC
WALT DISNEY INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025